Healthcare IT News December 20, 2021
The revised regulations mean providers can prescribe and mail abortion medication to patients without an in-person appointment in more than half the country.
The U.S. Food and Drug Administration last week modified its restrictions on mifepristone, one of the medications used in abortion. The new regulations enable abortion via telemedicine in more than half of the country.
“The in-person dispensing requirements on medication abortion care have proven to be unnecessary during the pandemic, and the FDA did the right thing today by lifting them,” said Kirsten Moore, director of the Expanding Medication Abortion Access Project, in a statement.
“Now patients can see a healthcare professional in a telehealth visit and then have the medications mailed to their home,”...
Today's Sponsors
Today's Sponsor